Company Overview
Park Dental Partners, Inc. operates as a dental resource organization that delivers business support services to dentists located throughout Minnesota and Wisconsin, providing clinical team members, administrative personnel, facilities, and equipment to affiliated general practitioners. The company functions within the Healthcare sector, specifically in the Medical Care Facilities industry, a classification that reflects its role in supporting the infrastructure of dental practices rather than directly providing patient care services. The firm holds a market capitalization of $69.44M and reported annual revenue of $244.49M, while the number of employees is not publicly disclosed in the available data. These valuation and revenue figures indicate a mid-sized enterprise operating within a specialized niche of the healthcare ecosystem, suggesting a business model focused on scalability through organizational support rather than individual practice ownership. The revenue scale of nearly $250 million implies a significant footprint in the regional dental market, allowing the entity to exercise influence over service delivery standards and operational efficiency across its network of affiliated locations.
Financial Health
The company reported revenue of $244.49M over the trailing twelve-month period, yet posted a net income of $-358,000, while generating an EBITDA of $12.34M. The substantial gap between the positive EBITDA and the negative net income reveals a cost structure where non-operating expenses, such as interest payments or taxes, are consuming operating profits to the point of erasing net earnings. Despite the reported net loss, the business generated free cash flow of $13.30M, which provides the organization with significant financial flexibility to fund operations, repay debt, or pursue strategic investments without relying on external capital markets. Profitability metrics further highlight this dynamic, with a gross margin of 18.1% indicating efficient production or service delivery costs relative to sales, an operating margin of -13.4% signaling that overhead and administrative costs exceed operating income, and a profit margin of -0.1% confirming the overall bottom-line loss. On the balance sheet, the company holds cash of $25.18M against total debt of $60.35M, resulting in a debt-to-equity ratio of 276.80, which characterizes the balance sheet as highly leveraged rather than conservative. Liquidity is assessed via a current ratio of 1.06, suggesting that the company possesses just enough current assets to cover its short-term liabilities, indicating a tight but manageable working capital position. Return on equity stands at -4.1% and return on assets at 1.1%, metrics that reveal management is currently destroying shareholder value relative to equity while maintaining a slight positive return on the total asset base.
Valuation Assessment
The trailing P/E ratio is not available due to the reported net loss, whereas the forward P/E is listed at 12.38, a discrepancy that implies market expectations for earnings normalization or growth in the coming fiscal periods. The price-to-book ratio is 3.18, indicating that the market values the company at a significant premium over its net asset book value, which often reflects intangible assets or growth potential not captured on the balance sheet. Alternative valuation metrics provide further context, with a price-to-sales ratio of 0.28 and an EV/EBITDA of 8.48, suggesting the stock is priced conservatively relative to its revenue and earnings power despite the negative net income. The stock's price volatility is framed by a 52-week high of $21.59 and a 52-week low of $9.53, meaning the current trading price sits at a specific point within this wide range, reflecting market uncertainty or a recent correction from historical peaks. While the beta value is not disclosed, the wide spread between the high and low suggests the stock has experienced considerable price movement relative to the broader market over the last year. The low price-to-sales multiple of 0.28 combined with a positive EV/EBITDA of 8.48 suggests the market is pricing the company based on cash flow generation potential rather than current profitability.
Growth & Income
Revenue growth year-over-year stands at 7.5%, while earnings growth is not applicable due to the negative net income, indicating that top-line expansion is outpacing the ability to generate bottom-line profits in the current cycle. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means the firm reinvests all available earnings and cash flow back into the business to fuel expansion or reduce debt. This reinvestment strategy is typical for growth-oriented dental support organizations that prioritize scaling their network of affiliated general practices over returning capital to shareholders. The overall growth and income profile is defined by solid revenue expansion and strong free cash flow generation, even as the company navigates a period of negative net income and high leverage. The absence of a dividend yield confirms that the primary vehicle for shareholder return is capital appreciation derived from future earnings normalization and operational improvements.